High-throughput flow cytometry purification of transduced progenitors expressing defined levels of vascular endothelial growth factor induces controlled angiogenesis in vivo.
about
Extracellular matrix and growth factor engineering for controlled angiogenesis in regenerative medicineGene therapy from the perspective of systems biology.Correlative Imaging of the Murine Hind Limb Vasculature and Muscle Tissue by MicroCT and Light Microscopy.Induction of aberrant vascular growth, but not of normal angiogenesis, by cell-based expression of different doses of human and mouse VEGF is species-dependent.Controlled angiogenesis in the heart by cell-based expression of specific vascular endothelial growth factor levels.Targeted Genome Engineering to Control VEGF Expression in Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells: Potential Implications for the Treatment of Myocardial Infarction.Muscle cell derived angiopoietin-1 contributes to both myogenesis and angiogenesis in the ischemic environment.Generation of human adult mesenchymal stromal/stem cells expressing defined xenogenic vascular endothelial growth factor levels by optimized transduction and flow cytometry purificationTherapeutic angiogenesis due to balanced single-vector delivery of VEGF and PDGF-BB.VEGF dose regulates vascular stabilization through Semaphorin3A and the Neuropilin-1+ monocyte/TGF-β1 paracrine axisThe effect of controlled expression of VEGF by transduced myoblasts in a cardiac patch on vascularization in a mouse model of myocardial infarctionLong-term safety and stability of angiogenesis induced by balanced single-vector co-expression of PDGF-BB and VEGF164 in skeletal muscle.Targeting Metabolic Symbiosis to Overcome Resistance to Anti-angiogenic Therapy.FACS-purified myoblasts producing controlled VEGF levels induce safe and stable angiogenesis in chronic hind limb ischemia.Cell and gene therapy approaches for cardiac vascularization.VEGF over-expression in skeletal muscle induces angiogenesis by intussusception rather than sprouting.Scaffold Composition Determines the Angiogenic Outcome of Cell-Based Vascular Endothelial Growth Factor Expression by Modulating Its Microenvironmental Distribution.Spontaneous In Vivo Chondrogenesis of Bone Marrow-Derived Mesenchymal Progenitor Cells by Blocking Vascular Endothelial Growth Factor Signaling.Vascular Endothelial Growth Factor Sequestration Enhances In Vivo Cartilage Formation.EphrinB2/EphB4 signaling regulates non-sprouting angiogenesis by VEGF.Angiogenic and osteogenic potentials of dental stem cells in bone tissue engineering.Myocardial infarction stabilization by cell-based expression of controlled Vascular Endothelial Growth Factor levels.
P2860
Q26829783-FF365921-2EBA-467C-A693-616EACA4C107Q30430438-C5B3C7FC-DFAB-4636-94BF-BD4B46DD1C3DQ30837730-5E2ECC69-1359-47C9-83F8-E8753A669217Q33586324-0EB13230-FB45-4C32-A32C-508629FDA513Q33586957-23366978-9311-4A4A-8979-2421BD0719C4Q33722274-F9752DEA-64D3-4FF1-87F0-FA9B5979DFFFQ35621136-88563EC8-AE99-48C5-911F-17C1D87C2D97Q35851399-E70AF361-416C-4F31-A8DA-2FCE2515D8E9Q35987897-35578F73-D049-4239-BAA0-3D5156D85ACDQ36159478-3FCDAF0B-3ED2-41F9-B5AB-8FA94A36640DQ36374351-6970C992-90BC-4BFF-B4C9-DA6368A8E244Q36587779-B4915F9D-0545-47FE-943C-2AB2D8759057Q36910309-74DDD45D-13A7-48E4-818C-FE289D27FD18Q37295222-C570BBEE-A18E-4884-9AA1-688EB5C03D64Q37512327-F5E6CFB4-4E10-4AF3-BDA7-44B66EE60482Q44037274-97053E65-A7BA-4CD1-9557-66D937894449Q45872982-F67F6961-1454-4CCE-9210-CF2CC46095B8Q46092429-F227C48A-A301-47EA-9EBF-EDEC9C7C5E9EQ47153246-2F76A28E-AF97-4376-88A0-4BCCE2A71A9FQ55004289-5430FDEE-D584-4DAA-BF61-F44B6FE3E8BFQ55371120-8D769CD3-E91E-49F7-BF63-D8A239D22A59Q55395190-1677A7F4-1F2E-4699-AADC-CE3698A809E4
P2860
High-throughput flow cytometry purification of transduced progenitors expressing defined levels of vascular endothelial growth factor induces controlled angiogenesis in vivo.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
High-throughput flow cytometry ...... ntrolled angiogenesis in vivo.
@en
High-throughput flow cytometry ...... ntrolled angiogenesis in vivo.
@nl
type
label
High-throughput flow cytometry ...... ntrolled angiogenesis in vivo.
@en
High-throughput flow cytometry ...... ntrolled angiogenesis in vivo.
@nl
prefLabel
High-throughput flow cytometry ...... ntrolled angiogenesis in vivo.
@en
High-throughput flow cytometry ...... ntrolled angiogenesis in vivo.
@nl
P2093
P2860
P356
P1433
P1476
High-throughput flow cytometry ...... ntrolled angiogenesis in vivo.
@en
P2093
Heidi Misteli
Lorenz Gürke
Michael Heberer
Philipp Füglistaler
Roberto Gianni-Barrera
Thomas Wolff
P2860
P304
P356
10.1002/STEM.291
P50
P577
2010-03-01T00:00:00Z